Table 1.
Characteristic | Mean (SD) | Range |
---|---|---|
Age at diagnosisa | 49.55 (11.02) | 29-74 |
Age at assessmenta | 55.85 (10.62) | 36-80 |
Time between diagnosis and assessmentb | 80.68 (80.33) | 2-445 |
Time between RT and assessmentb | 23.79 (32.85) | 0-93 |
Educationa | 15.78 (4.41) | 5-26 |
Tumor volume (cm3) | 22.89 (18.42) | 1-77 |
Radiation prescription dose (median [SD]) | 5468.02 (530.52) | 5000-7000 |
ROI mean radiation dose | ||
Cerebellum | 1221.39 (968.20) | 16-4291 |
Dorsal frontal | 1367.42 (1179.77) | 56-4462 |
Hippocampi | 1922.84 (1234.17) | 32-3932 |
Parietal-occipital | 936.23 (871.60) | 123-3142 |
Subcortical | 1665.60 (1017.30) | 63-3936 |
Ventral frontal | 2128.76 (1556.01) | 22-4832 |
ROI D50 radiation dose | ||
Cerebellum | 1082.25 (944.67) | 16-4485 |
Dorsal frontal | 1123.65 (1402.60) | 43-4951 |
Hippocampi | 1593.30 (1238.04) | 31-4130 |
Parietal-occipital | 776.12 (843.27) | 58-3003 |
Subcortical | 1467.12 (1105.28) | 54-4365 |
Ventral frontal | 2097.50 (1682.50) | 21-5371 |
Radiation fractions | 28.12 (2.90) | 25-35 |
N (%) | ||
Sex (male) | 21 (52.50) | |
Marital status (married) | 26 (65.00) | |
Surgery (yes) | 29 (72.50) | |
Antiepileptic medication (yes) | 9 (22.50) | |
Tumor grade | ||
I | 16 (40.00) | |
II | 12 (30.00) | |
Unresected | 11 (27.50) | |
Unknown | 1 (2.50) | |
Tumor location | ||
Frontal | 13 (32.50) | |
Suprasellar | 11 (27.50) | |
Temporal | 9 (22.50) | |
Occipital | 3 (7.50) | |
Parietal | 3 (7.50) | |
Multiple locations | 1 (2.50) | |
Tumor laterality | ||
Left | 18 (45.00) | |
Right | 17 (42.50) | |
Midline | 5 (12.50) | |
Radiation technique | ||
3DCRT | 2 (5.00) | |
IMRT | 28 (70.00) | |
VMAT | 10 (25.00) |
Abbreviations: 3DCRT, three-dimensional conformal RT therapy; assessment, neurocognitive assessment; IMRT, intensity-modulated RT therapy (ie, step-and-shoot); VMAT, volumetric modulated arc therapy.
aYears.
bMonths.